162 related articles for article (PubMed ID: 16329544)
1. Expression of proliferating cell associated protein, Ki-67, supports cellular proliferation in WHO Class IV lupus nephritis.
Cheah PL; Kunaseegaran R; Looi LM
Malays J Pathol; 2001 Jun; 23(1):27-30. PubMed ID: 16329544
[TBL] [Abstract][Full Text] [Related]
2. Enhanced major histocompatibility complex (MHC) class II antigen expression in lupus nephritis.
Cheah PL; Looi LM; Chua CT; Yap SF; Fleming S
Malays J Pathol; 1997 Dec; 19(2):115-20. PubMed ID: 10879251
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of apoptosis: a possible mechanism leading to chronic progressive renal histological changes in lupus nephritis.
Lu F; Shen W; Zhang X; Guo M; Lin S
Chin Med J (Engl); 2000 Dec; 113(12):1082-6. PubMed ID: 11776141
[TBL] [Abstract][Full Text] [Related]
5. Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response.
Papadimitraki ED; Tzardi M; Bertsias G; Sotsiou E; Boumpas DT
Lupus; 2009 Aug; 18(9):831-5. PubMed ID: 19578108
[TBL] [Abstract][Full Text] [Related]
6. Evidence of concurrent immunopathological mechanisms determining the pathology of severe lupus nephritis.
Schwartz MM; Korbet SM; Katz RS; Lewis EJ
Lupus; 2009 Feb; 18(2):149-58. PubMed ID: 19151117
[TBL] [Abstract][Full Text] [Related]
7. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
[TBL] [Abstract][Full Text] [Related]
8. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.
Hiramatsu N; Kuroiwa T; Ikeuchi H; Maeshima A; Kaneko Y; Hiromura K; Ueki K; Nojima Y
Rheumatology (Oxford); 2008 May; 47(5):702-7. PubMed ID: 18390590
[TBL] [Abstract][Full Text] [Related]
9. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis.
Marks SD; Williams SJ; Tullus K; Sebire NJ
Nephrol Dial Transplant; 2008 Nov; 23(11):3521-6. PubMed ID: 18495743
[TBL] [Abstract][Full Text] [Related]
10. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis.
Martinez-Lostao L; Ordi-Ros J; Balada E; Segarra-Medrano A; Majó-Masferrer J; Labrador-Horrillo M; Vilardell-Tarrés M
Lupus; 2007; 16(7):483-8. PubMed ID: 17670846
[TBL] [Abstract][Full Text] [Related]
11. [Lupus nephritis in children and adolescents (clinical-morphologic correlation)].
Bogdanović R; Mikuska M; Cvorić A; Nikolić V; Sindjić M; Ognjanović M; Abinun M
Srp Arh Celok Lek; 1994; 122(1-2):26-30. PubMed ID: 17972798
[TBL] [Abstract][Full Text] [Related]
12. Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases.
Carmona F; Font J; Moga I; Làzaro I; Cervera R; Pac V; Balasch J
Am J Reprod Immunol; 2005 Apr; 53(4):182-8. PubMed ID: 15760379
[TBL] [Abstract][Full Text] [Related]
13. Sex-based differences in lupus nephritis: a study of 235 Indian patients.
Soni SS; Gowrishankar S; Adikey GK; Raman A
J Nephrol; 2008; 21(4):570-5. PubMed ID: 18651548
[TBL] [Abstract][Full Text] [Related]
14. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
[TBL] [Abstract][Full Text] [Related]
15. Increased apoptosis and expression of FasL, Bax and caspase-3 in human lupus nephritis class II and IV.
Cui JH; Qiao Q; Guo Y; Zhang YQ; Cheng H; He FR; Zhang J
J Nephrol; 2012; 25(2):255-61. PubMed ID: 21725926
[TBL] [Abstract][Full Text] [Related]
16. High levels of complement C3a receptor in the glomeruli in lupus nephritis.
Mizuno M; Blanchin S; Gasque P; Nishikawa K; Matsuo S
Am J Kidney Dis; 2007 May; 49(5):598-606. PubMed ID: 17472841
[TBL] [Abstract][Full Text] [Related]
17. Lupus nephritis. Clinicopathological correlation.
Al-Zahrani IH; Qayyum A
Saudi Med J; 2007 Oct; 28(10):1503-5. PubMed ID: 17914508
[TBL] [Abstract][Full Text] [Related]
18. Correlation of clinical and pathological findings in patients with lupus nephritis: a five-year experience in Iran.
Nezhad ST; Sepaskhah R
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):32-40. PubMed ID: 18087120
[TBL] [Abstract][Full Text] [Related]
19. [Lupus nephritis in children and adolescents: clinical and morphologic aspects and clinico-morphologic correlations].
Bogdanović R; Nikolić V; Ognjanović M; Dimitrijević J; Marković-Lipkovski J; Pasić S; Minić A; Stajić N
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():1-5. PubMed ID: 12583306
[TBL] [Abstract][Full Text] [Related]
20. The prognosis and pathogenesis of severe lupus glomerulonephritis.
Schwartz MM; Korbet SM; Lewis EJ;
Nephrol Dial Transplant; 2008 Apr; 23(4):1298-306. PubMed ID: 18045825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
